Alternative strategy for rare mutations

Family members have large regions of sequence in common which limits precision of mapping. Rare mutations won’t be present in established SNP array assays. Exome sequencing of unrelated affected individuals ~5% sequencing cf whole genome. Screen sequences for nonsynonymous mutations (polymorphisms) in genes that are only present in the affected individuals. Gives precise identification of causative alleles